실시간
FierceBiotechADA: Lilly pulls back curtain on impressive triple-G efficacy in patients with obesity, diabetesClinical OMICsGLP-1 Drugs Lower Risk of Death by 44% in Obesity and Autoimmune DiseaseCellDeep-sea megafauna co-opts microbial energy metabolism genes to withstand ultra-long starvationCellReplaying germinal center evolution on a quantified affinity landscapeCellXenophagocytosis blockade enhances interspecies chimerismFierceBiotechADA: Pfizer pads case for berobenatide in obesity, adding validation to Metsera buyEndpoints News#ADA26: Pfizer monthly shot shows effect on obesity, diabetesEndpoints News#ADA26: Roche to start Phase 2 petrelintide, enicepatide combo trial this yearEndpoints NewsLawmakers propose China restrictions; #ASCO26 recap; and moreFierceBiotech‘It looks like this hypothesis will pan out’: Cullinan unveils data building case for autoimmune TCEsAmgenAmgen: A Biotech Giant's Path to Recovery and Growth - AOL.com
10x Genomics Blog 2025년 11월 26일

Is 10x Genomics Inc. stock safe for conservative investors - Weekly Earnings Recap & Reliable Momentum Entry Alerts - BỘ NỘI VỤ

Is 10x Genomics Inc. stock safe for conservative investors - Weekly Earnings Recap & Reliable Momentum Entry Alerts - BỘ NỘI VỤ

본문을 이용할 수 없습니다. 원본 출처를 확인하세요.